Literature DB >> 29380236

Drug related problems identified by clinical pharmacist at the Internal Medicine Ward in Turkey.

Nibal Abunahlah1, Anfal Elawaisi2, Fatih Mehmet Velibeyoglu3, Mesut Sancar4.   

Abstract

Background Drug-related problems (DRPs) interfere with patient optimal therapeutic outcomes and may be associated with higher morbidity, mortality and healthcare expenditures. Objective This study aimed to identify DRPs and their causes in a Turkish hospital. Setting Bakirkoy Dr. Sadi Konuk Teaching and Research Hospital, Internal Medicine Ward, Istanbul, Turkey. Method Cross-sectional study included a total of 100 patients. Patient demographics, medications, and history were evaluated. Data regarding recent medications were analyzed by two clinical pharmacists and an Internal Medicine physician. The DRPs were identified via V7.0 PCNE classification. Lexicomp® was used to assess the drug-drug interactions. UpToDate® recommendations and national guidelines were applied in the assessment of compliance with approved medication procedures. Main outcome measures Number and causes of the potential DRPs. Results At least one potential DRP was seen in 80% of the patients and 163 potential DRPs were identified (average = 1.6 DRPs/patient). The most common causes of DRPs were errors in drug selection (44.78%), dose selection (27.61%) and medication procedures (21.47%). There were significant correlations (p < 0.05) between DRPs and age (r = 0.4), number of drugs used (r = 0.32), duration of hospitalization (r = 0.25), renal impairment (r = - 0.34) and inflammation (r = 0.31). Conclusion The majority of the patients had DRPs. Patients with renal impairment, inflammation, polypharmacy or an extended hospital stay had a much higher chance of developing DRPs.

Entities:  

Keywords:  Dose selection; Drug-related problem; Medication procedure; Renal impairment; Turkey

Mesh:

Year:  2018        PMID: 29380236     DOI: 10.1007/s11096-017-0585-5

Source DB:  PubMed          Journal:  Int J Clin Pharm


  33 in total

1.  Prevalence of drug-related problems and cost-savings opportunities in medicaid high utilizers identified by a pharmacist-run drug regimen review center.

Authors:  Joanne LaFleur; Carrieann McBeth; Karen Gunning; Lynda Oderda; Carin Steinvoort; Gary M Oderda
Journal:  J Manag Care Pharm       Date:  2006-10

2.  Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems.

Authors:  Kirsten K Viktil; Hege S Blix; Tron A Moger; Aasmund Reikvam
Journal:  Br J Clin Pharmacol       Date:  2006-08-30       Impact factor: 4.335

Review 3.  Mechanisms of drug induced QT interval prolongation.

Authors:  Marcelo Luis Ponte; Guillermo Alberto Keller; Guillermo Di Girolamo
Journal:  Curr Drug Saf       Date:  2010-01

4.  Preventing potential drug interactions in community pharmacy.

Authors:  L L Lien; E J Lien
Journal:  J Clin Pharm Ther       Date:  1994-12       Impact factor: 2.512

Review 5.  Drug-related problems in hospitalised patients.

Authors:  P M van den Bemt; T C Egberts; L T de Jong-van den Berg; J R Brouwers
Journal:  Drug Saf       Date:  2000-04       Impact factor: 5.606

6.  The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals.

Authors:  Hege Salvesen Blix; Kirsten K Viktil; Asmund Reikvam; Tron Anders Moger; Bodil Jahren Hjemaas; Piia Pretsch; Tine Flindt Vraalsen; Elspeth K Walseth
Journal:  Eur J Clin Pharmacol       Date:  2004-10-02       Impact factor: 2.953

Review 7.  Trimetazidine for stable angina.

Authors:  A Ciapponi; R Pizarro; J Harrison
Journal:  Cochrane Database Syst Rev       Date:  2005-10-19

Review 8.  Drug-related problems in hospitals: a review of the recent literature.

Authors:  Anita Krähenbühl-Melcher; Raymond Schlienger; Markus Lampert; Manuel Haschke; Jürgen Drewe; Stephan Krähenbühl
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 9.  The impact of clinical pharmacists on drug-related problems and clinical outcomes.

Authors:  Kirsten K Viktil; Hege Salvesen Blix
Journal:  Basic Clin Pharmacol Toxicol       Date:  2008-01-30       Impact factor: 4.080

10.  Drug-related problems in a sample of outpatients with chronic diseases: a cross-sectional study from Jordan.

Authors:  Sayer I Al-Azzam; Karem H Alzoubi; Salah AbuRuz; Qais Alefan
Journal:  Ther Clin Risk Manag       Date:  2016-02-17       Impact factor: 2.423

View more
  14 in total

1.  Drug-Related Problems in Hospitalised Patients with Chronic Kidney Disease: A Systematic Review.

Authors:  Wadia S Alruqayb; Malcolm J Price; Vibhu Paudyal; Anthony R Cox
Journal:  Drug Saf       Date:  2021-09-12       Impact factor: 5.606

2.  Development of Key Performance Indicators for Capturing Impact of Pharmaceutical Care in Palestinian Integrative Healthcare Facilities: A Delphi Consensus Study.

Authors:  Ramzi Shawahna
Journal:  Evid Based Complement Alternat Med       Date:  2020-06-25       Impact factor: 2.629

3.  Quality Indicators of Pharmaceutical Care in Palestinian Integrative Healthcare Facilities: Findings of a Qualitative Study among Stakeholders.

Authors:  Ramzi Shawahna
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-10       Impact factor: 2.629

4.  Analysis of clinical pharmacist interventions in the neurology unit of a Brazilian tertiary teaching hospital.

Authors:  João Paulo Vilela Rodrigues; Fabiana Angelo Marques; Ana Maria Rosa Freato Gonçalves; Marília Silveira de Almeida Campos; Tiago Marques Dos Reis; Manuela Roque Siani Morelo; Andrea Fontoura; Beatriz Maria Pereira Girolineto; Helen Palmira Miranda de Camargo Souza; Maurílio de Souza Cazarim; Lauro César da Silva Maduro; Leonardo Régis Leira Pereira
Journal:  PLoS One       Date:  2019-01-18       Impact factor: 3.240

5.  Evaluation of pharmacist interventions and commonly used medications in the geriatric ward of a teaching hospital in Turkey: a retrospective study.

Authors:  Elif Ertuna; Mehmet Zuhuri Arun; Seval Ay; Fatma Özge Kayhan Koçak; Bahattin Gökdemir; Gül İspirli
Journal:  Clin Interv Aging       Date:  2019-03-21       Impact factor: 4.458

6.  Drug related problems in clinical practice: a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions.

Authors:  Noe Garin; Nuria Sole; Beatriz Lucas; Laia Matas; Desiree Moras; Ana Rodrigo-Troyano; Laura Gras-Martin; Nuria Fonts
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

7.  Clinical pharmacist assessment of drug-related problems among intensive care unit patients in a Turkish university hospital.

Authors:  Aslınur Albayrak; Bilgen Başgut; Gülbin Aygencel Bıkmaz; Bensu Karahalil
Journal:  BMC Health Serv Res       Date:  2022-01-15       Impact factor: 2.655

8.  Role of pharmacist during COVID-19 pandemic: A retrospective study focused on critically ill COVID-19 patients.

Authors:  Abdulrahman Alwhaibi; Abdulmohsin Alrwaished; Shoug Majed Binobydaan; Sawsan Alawwad; Syed Wajid; Salmeen Bablghaith; Sultan Alghadeer; Mohammed N Al Arifi
Journal:  Saudi Pharm J       Date:  2021-07-16       Impact factor: 4.330

9.  Incidence, types and acceptability of pharmaceutical interventions about drug related problems in a general hospital: an open prospective cohort.

Authors:  Valdjane Saldanha; Rand Randall Martins; Sara Iasmin Vieira Cunha Lima; Ivonete Batista de Araujo; Antonio Gouveia Oliveira
Journal:  BMJ Open       Date:  2020-04-23       Impact factor: 2.692

10.  Drug-Related Problems and Pharmacist Intervention at a General Hospital in the Jazan Region, Saudi Arabia.

Authors:  Salmeen D Babelghaith; Syed Wajid; Ziyad Alrabiah; Mohammed Abdu M Othiq; Sultan Alghadeer; Abdulaziz Alhossan; Mohamed Al-Arifi; Ibraheem M Attafi
Journal:  Risk Manag Healthc Policy       Date:  2020-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.